Craft

Medite

Stock Price

$0

2024-10-29

Market Capitalization

$520.3 K

2024-10-29

Revenue

$6.8 M

FY, 2017

Medite Summary

Company Summary

Overview
Medite Cancer Diagnostics (formerly CytoCore) is a company that specializes in the development, manufacture and distribution of medical laboratory instruments for pathology, histology, and cytology. It offers consumable products and equipment in particular for Liquid Based Cytology which is the important tool in cancer screening and detection in the field of cervical, breast, lung and other cancer types.
Type
Public
Status
Active
Founded
1998
HQ
Orlando, FL, US | view all locations
Website
https://www.medite.de/
Cybersecurity rating
Sectors

Key People

  • Michael Kenealy

    Michael Kenealy, U.S. Director of Sales

    • Gary Pickett

      Gary Pickett, CFO

      LocationsView all

      2 locations detected

      • Orlando, FL HQ

        United States

        4203 34th St

      • Burgdorf, NDS

        Germany

        Wollenweberstraße 12

      Medite Financials

      Summary Financials

      Revenue (Q3, 2018)
      $2.4M
      Gross profit (Q3, 2018)
      $1.5M
      Net income (Q3, 2018)
      ($735.0K)
      Cash (Q3, 2018)
      $147.0K
      EBIT (Q3, 2018)
      ($95.0K)
      Enterprise value
      $6.1M

      Footer menu